These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 33248018)

  • 1. Glucose or Insulin, Which Is the Culprit in Patients with COVID-19 and Diabetes?
    Donath MY
    Cell Metab; 2021 Jan; 33(1):2-4. PubMed ID: 33248018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin Treatment Is Associated with Increased Mortality in Patients with COVID-19 and Type 2 Diabetes.
    Yu B; Li C; Sun Y; Wang DW
    Cell Metab; 2021 Jan; 33(1):65-77.e2. PubMed ID: 33248471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycemic control metrics using flash glucose monitoring and hospital complications in patients with COVID-19.
    Gómez AM; Henao DC; Muñoz OM; Aschner P; Yepes CA; Jojoa R; Kerguelen A; Parra D; Jaramillo P; Umpierrez GE
    Diabetes Metab Syndr; 2021; 15(2):499-503. PubMed ID: 33662836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interrelationship between 2019-nCov receptor DPP4 and diabetes mellitus targets based on protein interaction network.
    Gao Q; Zhang W; Li T; Yang G; Zhu W; Chen N; Jin H
    Sci Rep; 2022 Jan; 12(1):188. PubMed ID: 34996987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and diabetes mellitus: from pathophysiology to clinical management.
    Lim S; Bae JH; Kwon HS; Nauck MA
    Nat Rev Endocrinol; 2021 Jan; 17(1):11-30. PubMed ID: 33188364
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do biomarkers of COVID-19 severity simply reflect a stress response in type 2 diabetes: Biomarker response to hypoglycemia.
    Moin ASM; Al-Qaissi A; Sathyapalan T; Atkin SL; Butler AE
    Metabolism; 2021 Jan; 114():154417. PubMed ID: 33157081
    [No Abstract]   [Full Text] [Related]  

  • 7. Angiotensin-converting enzyme 2, the complement system, the kallikrein-kinin system, type-2 diabetes, interleukin-6, and their interactions regarding the complex COVID-19 pathophysiological crossroads.
    Hoevenaar M; Goossens D; Roorda J
    J Renin Angiotensin Aldosterone Syst; 2020; 21(4):1470320320979097. PubMed ID: 33283602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A role of glycation and methylation for SARS-CoV-2 infection in diabetes?
    Sartore G; Ragazzi E; Faccin L; Lapolla A
    Med Hypotheses; 2020 Nov; 144():110247. PubMed ID: 33254553
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis of comorbidities in COVID-19: Which diseases increase the susceptibility of SARS-CoV-2 infection?
    Singh MK; Mobeen A; Chandra A; Joshi S; Ramachandran S
    Comput Biol Med; 2021 Mar; 130():104219. PubMed ID: 33486379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin in SARS-CoV-2 infection: A hidden path - from altered inflammation to reduced mortality. A review from the literature.
    Pedrosa AR; Martins DC; Rizzo M; Silva-Nunes J
    J Diabetes Complications; 2023 Feb; 37(2):108391. PubMed ID: 36621213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DPP4 Inhibitors and COVID-19-Holy Grail or Another Dead End?
    Krejner-Bienias A; Grzela K; Grzela T
    Arch Immunol Ther Exp (Warsz); 2021 Feb; 69(1):1. PubMed ID: 33527308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interaction of Severe Acute Respiratory Syndrome Coronavirus 2 and Diabetes.
    Shao S; Yang Q; Pan R; Yu X; Chen Y
    Front Endocrinol (Lausanne); 2021; 12():731974. PubMed ID: 34690930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacotherapeutic considerations for the management of diabetes mellitus among hospitalized COVID-19 patients.
    Hasan SS; Kow CS; Bain A; Kavanagh S; Merchant HA; Hadi MA
    Expert Opin Pharmacother; 2021 Feb; 22(2):229-240. PubMed ID: 33054481
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New Insulins, Biosimilars, and Insulin Therapy.
    Danne T; Heinemann L; Bolinder J
    Diabetes Technol Ther; 2017 Feb; 19(S1):S42-S58. PubMed ID: 28192016
    [No Abstract]   [Full Text] [Related]  

  • 15. Type-2 diabetes, a co-morbidity in Covid-19: does insulin signaling matter?
    Mishra D; Dey CS
    Biochem Soc Trans; 2021 Apr; 49(2):987-995. PubMed ID: 33666220
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic ketoacidosis and COVID-19: what have we learned so far?
    de Sá-Ferreira CO; da Costa CHM; Guimarães JCW; Sampaio NS; Silva LML; de Mascarenhas LP; Rodrigues NG; Dos Santos TL; Campos S; Young EC
    Am J Physiol Endocrinol Metab; 2022 Jan; 322(1):E44-E53. PubMed ID: 34779657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Remote Glucose Monitoring Platform for Multiple Simultaneous Patients at Coronavirus Disease 2019 Intensive Care Units: Case Report Including Adults and Children.
    Garelli F; Rosales N; Fushimi E; Arambarri D; Mendoza L; De Battista H; Sánchez-Peña R; García Arabehety J; Distefano S; Barcala C; Giunta J; Las Heras M; Martinez Mateu C; Prieto M; San Román E; Krochik G; Grosembacher L
    Diabetes Technol Ther; 2021 Jun; 23(6):471-473. PubMed ID: 33337261
    [No Abstract]   [Full Text] [Related]  

  • 18. COVID-19 severity in obese patients: Potential mechanisms and molecular targets for clinical intervention.
    Sharma JR; Yadav UCS
    Obes Res Clin Pract; 2021; 15(2):163-171. PubMed ID: 33509701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired glucose metabolism in patients with diabetes, prediabetes, and obesity is associated with severe COVID-19.
    Smith SM; Boppana A; Traupman JA; Unson E; Maddock DA; Chao K; Dobesh DP; Brufsky A; Connor RI
    J Med Virol; 2021 Jan; 93(1):409-415. PubMed ID: 32589756
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of SARS-CoV-2 Entry Factors in the Pancreas of Normal Organ Donors and Individuals with COVID-19.
    Kusmartseva I; Wu W; Syed F; Van Der Heide V; Jorgensen M; Joseph P; Tang X; Candelario-Jalil E; Yang C; Nick H; Harbert JL; Posgai AL; Paulsen JD; Lloyd R; Cechin S; Pugliese A; Campbell-Thompson M; Vander Heide RS; Evans-Molina C; Homann D; Atkinson MA
    Cell Metab; 2020 Dec; 32(6):1041-1051.e6. PubMed ID: 33207244
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.